Related Experiment Video

Updated: Jun 1, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

Advances in cardiology: clinical trial update

Andrew J Howe1, James A Shand, Ian B A Menown

  • 1Craigavon Cardiac Centre, Southern Trust, Northern Ireland, BT63 5QQ, UK.

Future Cardiology
|June 2, 2011
PubMed

Insights

Recent cardiology trials offer practice-changing insights. This review covers new findings in anticoagulation, antiplatelet therapy, heart failure treatments, and interventional cardiology, including novel devices and stent technologies.

Area of Science:

  • Cardiology
  • Clinical Trials
  • Interventional Cardiology

Background:

  • Numerous recent cardiology trials present findings with significant clinical practice implications.
  • Key areas include anticoagulation, antiplatelet therapy, heart failure management, and structural/coronary interventions.

Purpose of the Study:

  • To summarize and contextualize new trial findings in cardiology.
  • To provide clinicians with an overview of recent advancements and their potential impact on patient care.

Main Methods:

  • Review of recently presented and published clinical trials in cardiology.
  • Synthesis of trial data focusing on anticoagulation, antiplatelet therapy, heart failure, and interventional procedures.

Main Results:

  • New data on anticoagulants (enoxaparin, fondaparinux, heparin) in catheterization labs.
  • Insights into genetic polymorphisms and functional testing for antiplatelet agents (clopidogrel, ticagrelor).
  • Updates on novel oral anticoagulants (apixaban, rivaroxaban) for atrial fibrillation and heart failure therapies (ivabradine, eplerenone, CRT, stem cells).
  • Discussion of percutaneous structural interventions (TAVI, mitral implants, PFO devices) and advanced PCI (stents, IVUS).

Conclusions:

  • Recent trials offer significant updates for clinical cardiology practice.
  • Clinicians should be aware of new therapeutic options and technologies in anticoagulation, antiplatelet therapy, heart failure, and interventional cardiology.

More Related Videos

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...